NFKB1 and neoplasm: There is a need to strike a balance between the inhibition of the non-canonical NF-κB in OC cells which enables long-term resistance and tumor re-initiation from CSC and the activation of canonical NF-κB in immune cells to generate an effective anti-tumor immune response.